GCL
ABBV icon

Gouws Capital LLC’s AbbVie ABBV Stock Holding History

Gouws Capital LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$706K Hold
2,700
– – 0.33% 31
2026
Q2 		$679K Sell
2,700
-135
-5% -$29K 0.32% 33
2026
Q1 		$617K Sell
2,835
-20
-0.7% -$4.44K 0.33% 34
2025
Q4 		$652K Hold
2,855
– – 0.34% 33
2025
Q3 		$661K Hold
2,855
– – 0.36% 33
2025
Q2 		$530K Buy
2,855
+440
+18% +$81.8K 0.29% 34
2025
Q1 		$506K Buy
2,415
+60
+3% +$11.7K 0.3% 34
2024
Q4 		$418K Hold
2,355
– – 0.29% 32
2024
Q3 		$465K Hold
2,355
– – 0.31% 32
2024
Q2 		$404K Buy
2,355
+125
+6% +$20.7K 0.29% 31
2024
Q1 		$406K Hold
2,230
– – 0.31% 31
2023
Q4 		$346K Sell
2,230
-1,125
-34% -$164K 0.28% 34
2023
Q3 		$500K Hold
3,355
– – 0.42% 33
2023
Q2 		$452K Buy
3,355
+175
+6% +$25.7K 0.37% 34
2023
Q1 		$507K Buy
3,180
+320
+11% +$48.9K 0.45% 33
2022
Q4 		$462K Sell
2,860
-640
-18% -$98.1K 0.44% 34
2022
Q3 		$470K Sell
3,500
-215
-6% -$30.9K 0.47% 33
2022
Q2 		$569K Hold
3,715
– – 0.54% 32
2022
Q1 		$602K Sell
3,715
-15
-0.4% -$2.18K 0.49% 33
2021
Q4 		$505K Buy
+3,730
New +$441K 0.41% 37

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Gouws Capital LLC's ABBV Position: Q3 2026 in Review

Gouws Capital LLC held its AbbVie (ABBV) position steady in Q3 2026 at 2,700 shares worth $706K. The position accounts for 0.33% of the portfolio, ranked #31.

Gouws Capital LLC first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Gouws Capital LLC held 2,700 shares of AbbVie worth $706K as of Q3 2026.
  • Gouws Capital LLC left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.33% of Gouws Capital LLC's portfolio in Q3 2026, its #31 holding.
  • Gouws Capital LLC first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Gouws Capital LLC's 13F filing for Q3 2026, filed 9 Oct 2026.